Can a peptide be cyclized if the sequence was not originally designed for cyclization?
Often yes, but the sequence must be reviewed for available reactive groups, compatible residue spacing, preservation of biological activity, and the need for engineered handles. In some cases, a small sequence modification or linker provides a more practical route.
Which is better: head-to-tail or side-chain cyclization?
Neither is universally better. Head-to-tail closure provides a continuous backbone but consumes both termini. Side-chain cyclization offers more positional flexibility and can preserve the termini for labeling or conjugation.
Can cyclization interfere with receptor binding?
Yes. A poorly placed constraint can distort the pharmacophore or modify a critical residue. Bridge placement should be guided by known structure–activity relationships, binding data, or testing of multiple designs.
Should cyclization be performed on-resin or in solution?
The choice depends on the sequence, protecting-group scheme, ring size, solubility, and risk of intermolecular reactions. On-resin methods can provide pseudo-dilution and simplified cleanup, while solution cyclization allows greater conformational freedom.
Can multiple cyclization strategies be combined?
Yes. Bicyclic and multiply constrained peptides may combine disulfide, lactam, thioether, click, or linker-mediated chemistries, provided each reaction is chemoselective and compatible with the protecting-group plan.
What information should I provide for a design review?
Please provide the peptide sequence, desired cyclization method if known, required terminal states, known active residues, intended application, future labeling or conjugation needs, target quantity, and any relevant literature reference.
What happens when the requested chemistry is not feasible?
Our scientists explain the chemical limitation and evaluate alternatives such as changing residue spacing, introducing a functional handle, using a linker, preserving a different terminus, or selecting another bond-forming strategy.
Is a disulfide bridge suitable for intracellular use?
It may be useful when reduction-triggered opening is desired, but it can be unstable in reducing intracellular environments. A thioether or lactam bridge may be preferred when permanent closure is required.
Can I add a fluorescent dye after cyclization?
Yes, provided an appropriate terminus or side-chain handle is preserved. The cyclization and labeling order should be planned together to maintain chemoselectivity and protect fluorophore performance.
Can Bio-Synthesis recommend the cyclization site?
Yes. Our scientists can review the sequence, biological objective, structural information, known active residues, and downstream requirements to propose practical cyclization options for discussion.